{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:30:40Z","timestamp":1720283440196},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.diagmicrobio.2006.12.003","type":"journal-article","created":{"date-parts":[[2007,3,24]],"date-time":"2007-03-24T11:06:08Z","timestamp":1174734368000},"page":"S31-S38","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S","title":["Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis"],"prefix":"10.1016","volume":"57","author":[{"given":"Antonio","family":"Anzueto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Bishai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Pottumarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3201\/eid1003.030252","article-title":"Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes","volume":"10","author":"Albrich","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib2","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.50.5.1762-1767.2006","article-title":"Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil","volume":"50","author":"Alvarez-Sala","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib3","author":"American Lung Association"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib5","first-page":"S437","article-title":"The importance of appropriate treatment of chronic bronchitis","volume":"6","author":"Anzueto","year":"2000","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib6","doi-asserted-by":"crossref","unstructured":"Anzeuto A, Bishai WR, Pottumarthy S (2006) Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis: focus on cefdinir (in this supplement).","DOI":"10.1016\/j.diagmicrobio.2006.12.003"},{"issue":"Suppl B","key":"10.1016\/j.diagmicrobio.2006.12.003_bib7","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1155\/2003\/486285","article-title":"Canadian guidelines for the management of acute exacerbations of chronic bronchitis","volume":"10","author":"Balter","year":"2003","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-2000-9844","article-title":"Infections in acute exacerbation of chronic bronchitis: what are they and how do we know?","volume":"21","author":"Baughman","year":"2000","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib9","first-page":"689","article-title":"Acute exacerbation of chronic bronchitis: a primary care consensus guideline","volume":"10","author":"Brunton","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.diagmicrobio.2004.11.015","article-title":"Cefdinir: an oral alternative to parenteral cephems","volume":"51","author":"Chatterjee","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network","volume":"341","author":"Chen","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib13","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1378\/chest.127.6.2231","article-title":"Clinical significance of the infection-free interval in the management of acute bacterial exacerbations of chronic bronchitis","volume":"127","author":"Chodosh","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jac\/37.2.331","article-title":"Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments","volume":"37","author":"Cook","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2006.12.003_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pupt.2005.10.011","article-title":"Acute exacerbation of chronic bronchitis: need for an evidence-based approach","volume":"19","author":"Donner","year":"2006","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/jac\/45.6.851","article-title":"Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis","volume":"45","author":"Fogarty","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib17","author":"GOLD"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0149-2918(02)85125-6","article-title":"Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin","volume":"24","author":"Guay","year":"2002","journal-title":"Clin. Ther."},{"issue":"Suppl 8","key":"10.1016\/j.diagmicrobio.2006.12.003_bib19","first-page":"69S","article-title":"A double-blind randomized study of cefditoren vs cefuroxime for AECB","volume":"22","author":"Henry","year":"2001","journal-title":"J. Respir. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib20","first-page":"S427","article-title":"The role of infection in acute exacerbations of chronic obstructive pulmonary disease","volume":"6","author":"Hillberg","year":"2000","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0732-8893(00)00136-X","article-title":"Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species","volume":"37","author":"Johnson","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2005.12.008","article-title":"Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999\u20132003)","volume":"56","author":"Johnson","year":"2006","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-2000-9845","article-title":"Epidemiology of chronic bronchitis and acute infective exacerbations of chronic bronchitis","volume":"21","author":"Kim","year":"2000","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib25","first-page":"43","article-title":"Interaction of cefdinir with \u03b2-lactamases","volume":"20","author":"Labia","year":"1994","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib26","first-page":"S409","article-title":"Emerging resistance problems among respiratory tract pathogens","volume":"6","author":"Lister","year":"2000","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-2005-869539","article-title":"Epidemiology and global impact of chronic obstructive pulmonary disease","volume":"26","author":"Mannino","year":"2005","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"Suppl 7A","key":"10.1016\/j.diagmicrobio.2006.12.003_bib28","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1016\/j.amjmed.2005.05.012","article-title":"Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis","volume":"118","author":"Martinez","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nm839","article-title":"Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States","volume":"9","author":"McCormick","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1469-0691.2006.01396.x","article-title":"Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones","volume":"12","author":"Mensa","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diagmicrobio.2004.10.009","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project","volume":"51","author":"Mera","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib32","author":"National Heart Lung and Blood Institute"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib33","series-title":"National Committee for Clinical Laboratory Standards. M100-S13, Performance Standards for Antimicrobial Susceptibility Testing, 13th Informational Supplement","author":"NCCLS","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib34","series-title":"Omnicef (cefdinir)","author":"Package insert","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1742-1241.2000.tb11907.x","article-title":"A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis","volume":"54","author":"Paster","year":"2000","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2165\/00003495-200464130-00004","article-title":"Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections","volume":"64","author":"Perry","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0732-8893(03)00165-2","article-title":"Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000\u20132002)","volume":"47","author":"Sader","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib38","doi-asserted-by":"crossref","first-page":"380S","DOI":"10.1378\/chest.117.5_suppl_2.380S","article-title":"Infectious etiology of acute exacerbations of chronic bronchitis","volume":"117","author":"Sethi","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2005-869538","article-title":"Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease","volume":"26","author":"Sethi","year":"2005","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 7A","key":"10.1016\/j.diagmicrobio.2006.12.003_bib41","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/j.amjmed.2005.05.007","article-title":"A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria","volume":"118","author":"Slama","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1201-9712(00)90062-6","article-title":"International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis","volume":"4","author":"Van Herwaarden","year":"2000","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.12.003_bib43","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2165\/00003495-200464220-00009","article-title":"Cefditoren pivoxil: a review of its use in the treatment of bacterial infections","volume":"64","author":"Wellington","year":"2004","journal-title":"Drugs"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306004937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306004937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T04:54:00Z","timestamp":1683780840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889306004937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0732889306004937"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.12.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}